BLEEDING NEWS'20
Noviembre, Número 71
-
Preoperative plasma fibrinogen level and transfusion in cardiac surgery: a biphasic correlation
-
Outcomes Associated with 4-Factor Prothrombin Complex Concentrate Administration to Reverse Oral Factor Xa Inhibitors in Bleeding Patients
-
Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery
-
Detection of hypofibrinogenemia during cardiac surgery: a comparison of resonance-based thrombelastography with the traditional Clauss method
Octubre, Número 70
-
Four-Factor Prothrombin Complex Concentrate: An Indispensable Adjunct in Coagulopathy of Trauma Management - A Comparative Review of the Literature over 2 Decades
-
A Review of Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?
-
Thromboelastography to Detect Hypercoagulability and Reduced Fibrinolysis in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients
-
Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes
Septiembre, Número 69
-
Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy
-
Comparison of Hemostatic Outcomes in Patients Receiving Fixed-Dose vs. Weight-Based 4-Factor Prothrombin Complex Concentrate
-
The Need for Red Cell Support During Non-Cardiac Surgery Is Associated to Pre-Transfusion Levels of FXIII and the Platelet Count
-
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
Julio, Número 68
-
Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate
-
Interventional Algorithm in Gastrointestinal Bleeding-An Expert Consensus Multimodal Approach Based on a Multidisciplinary Team
-
The effects of hemodilution on coagulation in term parturients: an in vitro study utilizing rotational thromboelastometry
Junio, Número 67
-
The Use of 4F-PCC to Correct Direct Oral Anticoagulant-Induced Coagulopathy: An Observational Analysis
-
COVID-19 and its implications for thrombosis and anticoagulationç
-
Current Perspective on Fibrinogen Concentrate in Critical Bleeding
-
COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection
Mayo, Número 66
-
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
-
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
-
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
-
COVID-19 Coagulopathy in Caucasian patients
Abril, Número 65
-
Propuesta de recomendaciones de manejo de fármacos anticoagulantes y antiagregantes en los pacientes graves con infección por COVID-19
-
Prominent Changes in Blood Coagulation of Patients With SARS-CoV-2 Infection
Especial COVID-19
-
Recursos ISTH
-
Recursos ESICM
-
Búsqueda bibliográfica en PubMed con los criterios de búsqueda
-
Comunicados de CSL
Marzo, Número 64
-
Analysis of the hemostatic therapy in liver transplantation guided by rotational thromboelastometry or conventional laboratory tests
-
Utilization of 4-Factor Prothrombin Complex Concentrate for Reversal of Oral Factor Xa Inhibitor-Associated Acute Major Bleeding: A Case Series
-
Trials and Tribulations of Viscoelastic-Based Determination of Fibrinogen Concentration
-
Traumatic-Induced Coagulopathy as a Systems Failure: A New Window into Hemostasisibrinogen Concentrate to Cardiac Surgery Patients with Ongoing Bleeding does not Increase the Risk of Thromboembolic Complications or Death
Febrero, Número 63
-
Fibrinogen Concentrate to Cardiac Surgery Patients with Ongoing Bleeding does not Increase the Risk of Thromboembolic Complications or Death
-
Modified version of the American College of Cardiology's recommendation for low-dose prothrombin complex concentrate is effective for warfarin reversal
-
Pediatric non-red cell blood product transfusion practices: what's the evidence to guide transfusion of the 'yellow' blood products?
-
A retrospective register study comparing fibrinogen treated trauma patients with an injury severity score matched control group
Enero, Número 62
-
Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood transfusion
-
Reversal of warfarin anticoagulation in geriatric traumatic brain injury due to ground-level falls
-
The prophylactic use of fibrinogen concentrate in high-risk cardiac surgery
-
Four-Factor Prothrombin Complex Concentrate for the Reversal of Direct Oral Anticoagulants